Ohr Pharmaceutical to Present at 2016 Ophthalmology Innovation Summit on October 13
Oct 11, 2016 12:02 pm UTC| Business
NEW YORK, Oct. 11, 2016 -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that the company has been selected to present at the 2016 Ophthalmology Innovation...
Ohr Pharmaceutical to Present at 2016 Ophthalmology Innovation Summit on October 13
Oct 11, 2016 12:02 pm UTC| Business
NEW YORK, Oct. 11, 2016 -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that the company has been selected to present at the 2016 Ophthalmology Innovation...
Ohr Pharmaceutical to Present at 2016 Ophthalmology Innovation Summit on October 13
Oct 11, 2016 12:02 pm UTC| Business
NEW YORK, Oct. 11, 2016 -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that the company has been selected to present at the 2016 Ophthalmology Innovation...
Oct 11, 2016 12:02 pm UTC| Business
Reception to also feature update on ADXS-NEO: Personalizing Immunotherapy PRINCETON, N.J., Oct. 11, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies,...
Oct 11, 2016 12:02 pm UTC| Business
Reception to also feature update on ADXS-NEO: Personalizing Immunotherapy PRINCETON, N.J., Oct. 11, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies,...
Oct 11, 2016 12:02 pm UTC| Business
Reception to also feature update on ADXS-NEO: Personalizing Immunotherapy PRINCETON, N.J., Oct. 11, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies,...
Oct 11, 2016 12:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...